Results for tag: "Tenosynovial Giant Cell Tumors Drug"

Tenosynovial Giant Cell Tumors (TGCT) are a rare type of cancer that affects the soft tissues of the body, such as the tendons, ligaments, and joint capsules. TGCTs are usually benign, but can become malignant if left untreated. Treatment for TGCTs typically involves surgery, radiation, and chemotherapy. Oncology drugs are used to treat TGCTs, and can include targeted therapies, immunotherapies, and hormone therapies. The Tenosynovial Giant Cell Tumors Drug market is a rapidly growing segment of the oncology drug market. It is driven by the increasing prevalence of TGCTs, as well as the development of new and innovative treatments. Companies in the market include Novartis, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more